Table 2.
Variable | DFS |
|||||
---|---|---|---|---|---|---|
Univariate |
Multivariate |
|||||
HR | 95% CI | P-value | HR | 95% CI | P-value | |
Male sex | 1.459 | 0.618–3.444 | 0.389 | |||
Age | 0.995 | 0.966–1.025 | 0.737 | |||
Body mass index | 1.012 | 0.890–1.150 | 0.861 | |||
CCI, < 4 | 0.642 | 0.278–1.482 | 0.299 | |||
Tumor location | 0.897 | |||||
Right | 1.000 | |||||
Left | 1.057 | 0.460–2.429 | ||||
Differentiation | 0.006 | 0.005 | ||||
WD, MD | 1.000 | 1.000 | ||||
PD, othersa | 4.730 | 1.555–14.386 | 4.994 | 1.610–15.489 | ||
Size | 0.929 | 0.747–1.156 | 0.510 | |||
T stage | 0.058 | |||||
pT4a | 1.000 | |||||
pT4b | 0.383 | 0.142–1.034 | ||||
Positive node | 0.860 | 0.006–0.006 | 0.808 | |||
Invasion | ||||||
Lymphatic | 1.793 | 0.703–4.577 | 0.222 | |||
Vascular | 3.752 | 0.503–27.969 | 0.197 | |||
Perineural | 1.578 | 0.686–3.630 | 0.283 | |||
CEA | 0.992 | 0.971–1.014 | 0.491 | |||
Laparoscopic | 0.332 | 0.144–0.762 | 0.009 | 0.323 | 0.140–0.747 | 0.008 |
Adjuvant chemotherapy | 1.425 | 0.329–6.169 | 0.635 |
HR, hazard ratio; CI, confidence interval; CCI, Charlson comorbidity index; WD, well differentiated; MD, moderate differentiated; PD, poorly differentiated; p, pathologic; CEA, carcinoembryonic antigen.
Mucinous carcinoma and signet ring cell.